Aldehyde dehydrogenase activity
- Animals1
Latest
American Journal of Physiology Heart and Circulatory Physiology
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling
Trial in peopleInterventions